U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770789) titled 'Clinical Trial to Study the Efficacy and Safety of Rejeunesse Shape With Lidocaine (HA Filler) in Treating Healthy Subjects' on Aug. 10.
Brief Summary: Intend to prove the non-inferiority of Rejeunesse against the comparing medical device of Restylane Perlane in terms of improvement, efficacy, and safety of nasolabial fold on the face
Study Start Date: Feb. 15, 2016
Study Type: INTERVENTIONAL
Condition:
Nasolabial Fold Correction
Intervention:
DEVICE: Rejeunesse
The clinical medical device, Rejeunesse, is a cross-lined HA hydrogel made by using the cross-linker of 1, 4-butandiol diglycidyl ether (BDDE) with low toxicity from ...